CD34 and nervous system disorder: Although we did not test the behaviour of these animals following transplantation with human CD34+ HSCs, these findings highlight the possibility of using human BM-derived HSCs to potentially treat and repair a wide range of neurological disorders, primarily those whose treatments rely on long-term passage across the blood-brain barrier.